Metabolic & Cardiometabolic · Gut & Microbiome
metabolic endotoxemia (LPS) causes GLP-1 resistance
In plain terms: Does gut inflammation blunt the appetite/blood-sugar hormone GLP-1?
Probably modestly yes — inflammation seems to dampen the hormone's signal, but this is shown mainly in animals and the lab.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Inflammation/LPS blunts GLP-1 signaling two ways: impaired FXR/TGR5-mediated secretion, and GLP-1-RECEPTOR silencing via promoter hypermethylation (DNMT3A/3B). 'GLP-1 resistance' is ligand- and receptor-side. Animal/mechanism-grade.
The evidence (13)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Deng G, Ren J, Li R, Zhang C, Gao X, Gao Y, Guo Q, Xu S, Wang G 2026 · Biochem Pharmacol | in-vitro | supports | moderate | LPS->DNMT3->GLP-1R promoter hypermethylation->reduced receptor (resistance mechanism) ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R 2007 · Diabetes | animal | supports | high | Foundational: metabolic endotoxemia (LPS infusion/HFD) initiates obesity and insulin resistance and disrupts the gut-incretin metabolic milieu in mice |
| Balogun O et al 2026 · Nutrients | animal | supports | moderate | Rodent (HFD-fed mice) model: quercetin restored intestinal barrier integrity, reducing plasma LPS by 36% and increasing GLP-1 by 23% versus HFD-alone controls. Shows an inverse LPS-GLP-1 relationship consistent with LPS suppressing GLP-1 se |
| Kishida Y, Okubo H, Ohno H, Oki K, Yoneda M 2017 · J Gastroenterol | animal | mixed | low | Miglitol increased GLP-1 and suppressed endotoxemia in NASH model; reciprocal link supports endotoxemia impairing the GLP-1 axis |
| Ahn CH, Kim EK, Min SH, Oh TJ, Cho YM 2017 · Diabetes Obes Metab | RCT | mixed | moderate | DPP4 inhibitor gemigliptin reduced postprandial ApoB48 in T2DM but whether systemic endotoxin is lowered remained inconclusive |
| Long J, Zhao J, Gu X, Huang C 2026 · Front Endocrinol | mechanism | mixed | low | Narrative review of post-transplant diabetes, no new data: 'we propose a unifying gut-immune-metabolic axis'. Its GLP-1 link is asserted, and runs through bile acids and secretion rather than LPS-driven GLP-1 resistance: 'Bile acid dysregulation->impaired FXR/TGR5 signaling->reduced enteroendocrine GLP-1 secretion->attenuated postprandial insulin response.' Review - zero weight. |
| Nakamori H, Niimi A, Mitsui R, Hashitani H 2024 · J Physiol | animal | contradicts | moderate | Luminal LPS stimulates GLP-1 release from colonic L cells via TLR4 (LPS raises, not blunts, GLP-1) |
| Anhê FF, Barra NG, Cavallari JF, Henriksbo BD, Schertzer JD 2021 · Cell Rep | animal | supports | high | Metabolic endotoxemia effect dictated by LPS lipid-A acylation; LPS structure drives inflammatory/metabolic (incl incretin-axis) dysfunction in obese mice |
| Wongkrasant P, Pongkorpsakol P, Chitwattananont S, Satianrapapong W, Tuangkijkul N, Muanprasat C 2020 · J Pharmacol Sci | animal | supports | moderate | Intestinal inflammation drove L-cell apoptosis via NF-kB-iNOS-caspase-3 lowering GLP-1; FOS rescued GLP-1 levels, evidencing inflammation-impaired GLP-1 |
| Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros JP, Le Guern N, Plesnik J, Thomas C, Bourgeois T, Dejong CHC, Kox M, Hundscheid IHR, Khan NA, Mandard S, Deckert V, Pickkers P, Drucker DJ, Lagrost L, Grober J 2017 · Cell Rep | animal | contradicts | moderate | Acute LPS RAISES GLP-1 via TLR4 (mice+humans) - opposite of secretory resistance |
| Zong Y, Chen W, Zhao Y, Suo X, Yang X 2022 · Int J Mol Sci | animal | mixed | low | Salmonella/endotoxin lowers blood GLP-1 by triggering enteroendocrine L-cell pyroptosis |
| Oh TJ, Lee HJ, Cho YM 2015 · Obes Surg | animal | supports | moderate | Ileal transposition lowered plasma LPS and raised L-cell secretion with improved insulin sensitivity, implying endotoxemia suppresses GLP-1 output |
| Wang P, Sun H, Maitiabula G, Zhang L, Yang J, Zhang Y, Gao X, Li J, Xue B, Li CJ, Wang X 2023 · Nat Metab | animal | supports | high | Total parenteral nutrition altered gut microbiota/metabolites impairing glucose metabolism; a GLP-1 receptor agonist fully prevented the disorder |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.